Related Experiment Video
Updated: Jun 13, 2025
Polyethyleneimine-coated Iron Oxide Nanoparticles as a Vehicle for the Delivery of Small Interfering RNA to Macrophages In Vitro and In Vivo
Published on: February 5, 2019
Lipid nanoparticle-mediated RNA delivery for immune cell modulation.
Emily H Kim1, Sridatta V Teerdhala1, Marshall S Padilla1
1Department of Bioengineering, School of Engineering and Applied Science, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Lipid nanoparticles (LNPs) are advanced delivery systems for nucleic acid therapies. This review explores LNP applications in immunotherapy for T cells, NK cells, macrophages, stem cells, and dendritic cells, highlighting their potential in cancer treatment.
Area of Science:
- Immunology
- Nanotechnology
- Biomedical Engineering
Background:
- Lipid nanoparticles (LNPs) are leading nonviral vectors for nucleic acid therapeutics, notably in mRNA COVID-19 vaccines.
- Their modularity and safety make LNPs suitable for diverse applications beyond vaccines, including immunoengineering.
- LNPs are increasingly explored for cancer immunotherapies by modulating immune cell function through nucleic acid delivery.
Purpose of the Study:
- To review methods and applications of LNP-based immunotherapy across five key immune cell types.
- To discuss the challenges and delivery barriers associated with each cell type.
- To highlight the potential of LNPs in developing novel clinical therapeutics.
Main Methods:
- Literature review focusing on LNP delivery systems for immunotherapy.
- Analysis of LNP applications in T cells, NK cells, macrophages, stem cells, and dendritic cells.
- Examination of immunological and nanotechnological strategies for enhanced LNP efficacy.
Main Results:
- LNPs demonstrate significant potential for modulating immune cells and their functionality.
- Specific LNP strategies can overcome delivery barriers in targeted immune cell types.
- LNP-based approaches offer versatile platforms for cancer immunotherapy development.
Conclusions:
- Lipid nanoparticles are a promising platform for advancing cancer immunotherapy.
- Targeted LNP delivery can enhance immune cell function for therapeutic benefit.
- Integrating immunology and nanotechnology with LNPs paves the way for novel clinical treatments.
Related Concept Videos
02:15Experimental RNAi
01:23RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
02:30siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...